ATE213942T1 - Pharmazeutische zusammensetzungen die isochinolinderivate enthalten - Google Patents
Pharmazeutische zusammensetzungen die isochinolinderivate enthaltenInfo
- Publication number
- ATE213942T1 ATE213942T1 AT94120240T AT94120240T ATE213942T1 AT E213942 T1 ATE213942 T1 AT E213942T1 AT 94120240 T AT94120240 T AT 94120240T AT 94120240 T AT94120240 T AT 94120240T AT E213942 T1 ATE213942 T1 AT E213942T1
- Authority
- AT
- Austria
- Prior art keywords
- agents
- isoquinoline derivatives
- present
- compositions containing
- pharmaceutical compositions
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 3
- AWJUIBRHMBBTKR-UHFFFAOYSA-N isoquinoline Chemical class C1=NC=CC2=CC=CC=C21 AWJUIBRHMBBTKR-UHFFFAOYSA-N 0.000 title 1
- 230000002401 inhibitory effect Effects 0.000 abstract 2
- 125000002183 isoquinolinyl group Chemical class C1(=NC=CC2=CC=CC=C12)* 0.000 abstract 2
- 108010044467 Isoenzymes Proteins 0.000 abstract 1
- 102000004861 Phosphoric Diester Hydrolases Human genes 0.000 abstract 1
- 108090001050 Phosphoric Diester Hydrolases Proteins 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 239000002260 anti-inflammatory agent Substances 0.000 abstract 1
- 229940121363 anti-inflammatory agent Drugs 0.000 abstract 1
- 239000000043 antiallergic agent Substances 0.000 abstract 1
- 239000000924 antiasthmatic agent Substances 0.000 abstract 1
- 239000000935 antidepressant agent Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000002934 diuretic Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 239000002445 liver protective agent Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000003204 tranquilizing agent Substances 0.000 abstract 1
- 230000002936 tranquilizing effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Hospice & Palliative Care (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP35148193A JP3276762B2 (ja) | 1993-12-28 | 1993-12-28 | イソキノリン誘導体を含有する医薬組成物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE213942T1 true ATE213942T1 (de) | 2002-03-15 |
Family
ID=18417586
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT94120240T ATE213942T1 (de) | 1993-12-28 | 1994-12-20 | Pharmazeutische zusammensetzungen die isochinolinderivate enthalten |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US5556862A (de) |
| EP (1) | EP0664127B1 (de) |
| JP (1) | JP3276762B2 (de) |
| AT (1) | ATE213942T1 (de) |
| DE (1) | DE69430047T2 (de) |
| ES (1) | ES2173901T3 (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7115661B1 (en) | 1999-12-29 | 2006-10-03 | Queen's University At Kingston | Methods and compositions for mitigating pain |
| IT1296985B1 (it) | 1997-12-19 | 1999-08-03 | Zambon Spa | Derivati benzazinici inibitori della fosfodiesterasi 4 |
| IT1302677B1 (it) | 1998-10-15 | 2000-09-29 | Zambon Spa | Derivati benzazinici inibitori della fosfodiesterasi 4 |
| US6562837B1 (en) * | 1998-10-21 | 2003-05-13 | Korea Institute Of Science & Technology | Use of tetrahydroisoquinoline compounds for the treatment of septicemia |
| IL149106A0 (en) * | 2001-04-20 | 2002-11-10 | Pfizer Prod Inc | Therapeutic use of selective pde10 inhibitors |
| RU2232018C2 (ru) * | 2002-10-09 | 2004-07-10 | Открытое акционерное общество "Ирбитский химико-фармацевтический завод" | Спазмолитическое лекарственное средство |
| RU2252024C2 (ru) * | 2003-04-22 | 2005-05-20 | Гаврилов Андрей Станиславович | Способ получения спазмолитического лекарственного средства |
| EP2156847A1 (de) * | 2008-08-19 | 2010-02-24 | Sanofi-Aventis | Neue Kombination von Wirkstoffen mit einem alpha1-Antagonisten und einem PDE-4-Hemmer |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU167246B (de) * | 1973-01-25 | 1975-09-27 | ||
| HU194179B (en) * | 1985-10-03 | 1988-01-28 | Chinoin Gyogyszer Es Vegyeszet | Process for production of 1-/3',4'-dietoxi-benzil/-1,6,7-dietoxi-3,4-dihydro-izoquinolinine-teophilin-7-acetate and their new cristallic monohydrate |
| HU197207B (en) * | 1985-12-04 | 1989-03-28 | Chinoin Gyogyszer Es Vegyeszet | Process for producing pharmaceutical comprising 1-(3',4'-diethoxybenzyl)-6,7-diethoxy-3,4-dihydro-isoquinolinium-theophylline-7-acetate or its monohydrate as active ingredient |
| US4956371A (en) * | 1989-09-19 | 1990-09-11 | Euroceltique, S.A. | Substituted isoquinolines and methods of using same |
| EP0557290A1 (de) * | 1990-08-23 | 1993-09-01 | The Children's Medical Center Corporation | Behandlung von aids-assoziierter dementia, myelopathie, peripherer neuropathie und sehverlust |
| HUT60926A (en) * | 1991-04-12 | 1992-11-30 | Chinoin Gyogyszer Es Vegyeszet | Process for producing pharmaceutical composition suitable for reducing or preventing increased thrombocyte-aggregation capability |
-
1993
- 1993-12-28 JP JP35148193A patent/JP3276762B2/ja not_active Expired - Fee Related
-
1994
- 1994-12-20 AT AT94120240T patent/ATE213942T1/de active
- 1994-12-20 EP EP94120240A patent/EP0664127B1/de not_active Expired - Lifetime
- 1994-12-20 DE DE69430047T patent/DE69430047T2/de not_active Expired - Lifetime
- 1994-12-20 ES ES94120240T patent/ES2173901T3/es not_active Expired - Lifetime
- 1994-12-21 US US08/360,630 patent/US5556862A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| US5556862A (en) | 1996-09-17 |
| ES2173901T3 (es) | 2002-11-01 |
| DE69430047D1 (de) | 2002-04-11 |
| JPH07196509A (ja) | 1995-08-01 |
| DE69430047T2 (de) | 2002-10-17 |
| EP0664127A3 (de) | 1999-12-29 |
| EP0664127A2 (de) | 1995-07-26 |
| JP3276762B2 (ja) | 2002-04-22 |
| EP0664127B1 (de) | 2002-03-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL109526A0 (en) | Benzofuranyl- and thiophenyl-alkanecarboxylic acid derivatives, their preparation and pharmaceutical compositions containing them | |
| DE69716461D1 (de) | Antithrombotische organische nitrate | |
| CA2398620A1 (en) | Pyrazine derivatives, pharmaceutical compositions containing them, and intermediates therefor | |
| AU692090B2 (en) | Novel 4,6-diarylpyrimidine derivatives and salts thereof | |
| AU8149894A (en) | Substituted phenyl compounds | |
| WO2004103977A3 (en) | Process for the preparation of pyrimidine derivatives | |
| EP0353955A3 (de) | Chemische Verbindungen | |
| IL114785A0 (en) | Pyrrolocarbazoles their preparation and pharmaceutical compositions containing them | |
| ATE213942T1 (de) | Pharmazeutische zusammensetzungen die isochinolinderivate enthalten | |
| CA2079548A1 (en) | Carbamate derivatives of 4-amino-3- isoxazolidinones, 3-amino-1- hydroxypyrrolidin-2-ones and 1-amino-1- cyclopropanecarboxylic acid analogs, a process for their preparation and their use as medicaments | |
| EP0712398A1 (de) | Benzopyrane und diese enthaltende pharmazeutische zusammenstellungen | |
| RU94046387A (ru) | Производные пиримидина, способ их получения, фармацевтическая композиция, ее применение и промежуточные продукты | |
| CA2191850A1 (en) | Cancerous metastasis inhibitor | |
| AU3559793A (en) | New 3-aminochroman spiro compounds, processes for their preparation and pharmaceutical compositions containing them | |
| MY103502A (en) | Novel compounds | |
| AU576926B2 (en) | Tetrazole derivatives | |
| JPS55100380A (en) | 11imidazoll22ylidenee33heterocyclic urea derivative*its manufacture and pharmaceutic composition having antidepressive activity | |
| DE3668888D1 (de) | Ein imidazolidintrion-derivat oder ein seiner pharmazeutisch akzeptierbaren salze enthaltende pharmazeutische zusammenstellung. | |
| HRP20060023A2 (en) | Use of bicyclo[2.2.1]heptane derivatives for the preparation of neuroprotective pharmaceutical compositions | |
| CA2108817A1 (en) | Arylidene-1-azacycloalkanes and arylalkyl-1-azacycloalkanes, their salts, medicaments containing these compounds and their use, and processes for their preparation | |
| CA2335394A1 (en) | Aerothricin analogs, their preparation and use | |
| CA2326716A1 (en) | Triazolopurine derivative, pharmaceutical composition containing the derivative, adenosine a3 receptor ligand, and remedy for asthma | |
| HK47592A (en) | Piperazine derivatives | |
| SE7905051L (sv) | Nya sulfonamider | |
| HK47492A (en) | Piperazine derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |